Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Clinical Cancer Research

• Publication date

  1999-11-01

• Fields of study

  Medicine

• Identifiers
  PMID 10589744
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p-Glycoprotein expression as a predictor of breast cancer recurrence

  2006cited by this paper
• Multidrug resistance: molecular mechanisms and clinical relevance

  1997cited by this paper
• Mechanisms of drug resistance in hematologic malignancies.

  1997cited by this paper
• Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein

  1997cited by this paper
• The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.

  1997cited by this paper
• Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry.

  1996cited by this paper
• The P-glycoprotein multidrug transporter.

  1996cited by this paper
• Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.

  1995cited by this paper
• Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome.

  1995cited by this paper
• Acute Induction of Adriamycin‐resistance in Human Colon Carcinoma HT‐29 Cells Exposed to a Sublethal Dose of Adriamycin

  1995cited by this paper
• Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection.

  1993cited by this paper
• Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.

  1993cited by this paper
• Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction.

  1992cited by this paper
• Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells.

  1990cited by this paper
• Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.

  1990cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper

• Discovery of drug transporter inhibitors tied to long noncoding RNA in resistant cancer cells; a computational model -in silico- study

  2025cites this paper
• Adaptive cancer therapy: can non-genetic factors become its achilles heel?

  2025cites this paper
• Antiproliferative Activity of Cephalotaxus Esters: Overcoming Chemoresistance.

  2024cites this paper
• The Natural Product Parthenolide Inhibits Both Angiogenesis and Invasiveness and Improves Gemcitabine Resistance by Suppressing Nuclear Factor κB Activation in Pancreatic Cancer Cell Lines

  2024cites this paper
• A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC

  2023cites this paper
• Brain Tumors: Development, Drug Resistance, and Sensitization – An Epigenetic Approach

  2023cites this paper
• Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming.

  2023cites this paper
• Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters

  2023cites this paper
• [Role of ABC Transporters in Cancer Development and Malignant Alteration].

  2022cites this paper
• TM2, a novel semi-synthetic taxoid, exerts anti-MDR activity in NSCLC by inhibiting P-gp function and stabilizing microtubule polymerization

  2022cites this paper
• Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches

  2022cites this paper
• A novel method for potentiation of chemotherapy in soft tissue sarcomas with BromAc.

  2022cites this paper
• Emerging Nano-Based Strategies Against Drug Resistance in Tumor Chemotherapy

  2021cites this paper
• Efflux pumps, NHE1, monocarboxylate transporters, and ABC transporter subfamily inhibitors

  2021cites this paper
• Intracellular Water Lifetime as a Tumor Biomarker to Monitor Doxorubicin Treatment via FFC-Relaxometry in a Breast Cancer Model

  2021cites this paper
• Loperamide potentiates doxorubicin sensitivity in triple‐negative breast cancer cells by targeting MDR1 and JNK and suppressing mTOR and Bcl‐2: In vitro and molecular docking study

  2021cites this paper
• The significance of HERC5, IFIH1, SAMD4, SEMA3A and MCTP1 genes expression in resistance to cytotoxic drugs in ovarian cancer cell lines

  2021cites this paper
• The effects of metformin on autophagy.

  2021cites this paper
• Integrating evolutionary dynamics into cancer therapy

  2020cites this paper
• Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target

  2020cites this paper
• Crocin Increases Gastric Cancer Cells’ Sensitivity to Doxorubicin

  2020cites this paper
• Therapy Resistance in Cancers: Phenotypic, Metabolic, Epigenetic and Tumour Microenvironmental Perspectives.

  2020cites this paper
• Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway

  2020cites this paper
• Empagliflozin and Doxorubicin Synergistically Inhibit the Survival of Triple-Negative Breast Cancer Cells via Interfering with the mTOR Pathway and Inhibition of Calmodulin: In Vitro and Molecular Docking Studies.

  2020cites this paper
• Genetic and epigenetic modulation of drug resistance in cancer: Challenges and opportunities.

  2020cites this paper
• Role of ATP-binding cassette transporters in cancer initiation and progression.

  2020cites this paper
• Synergistic Nanoparticle Formulations against Multi-drug Resistant Breast Cancers

  2019cites this paper
• Resistance to Anti-Cancer Therapeutics

  2019cites this paper
• Glucose starvation induces resistance to metformin through the elevation of mitochondrial multidrug resistance protein 1

  2019cites this paper
• ALTERING THE EXPRESSION OF P-GLYCOPROTEIN RESPONSIBLE FOR CHEMOTHERAPEUTIC DRUG RESISTANCE IN HEPG2 CELL LINE POST-TREATMENT WITH UREA AND β-MERCAPTOETHANOL

  2019cites this paper
• [Role of protein kinase D1 in regulating the growth, apoptosis and drug sensitivity of oral squamous carcinoma cells].

  2019cites this paper
• ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells1

  2018cites this paper
• The emerging role of long non-coding RNAs in the drug resistance of colorectal cancer.

  2018cites this paper
• How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?

  2018cites this paper
• Haplotypes of ABCB1 1236C >T (rs1128503), 2677G >T/A (rs2032582), and 3435C >T (rs1045642) in patients with bullous pemphigoid

  2018cites this paper
• Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy

  2018cites this paper
• Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) gene

  2018cites this paper
• ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells

  2018cites this paper
• Molecular bases of Sorcin-dependent resistance to chemotherapeutic agents

  2018cites this paper
• Graphene Quantum Dots Downregulate Multiple Multidrug‐Resistant Genes via Interacting with Their C‐Rich Promoters

  2017cites this paper
• The Functions of EP300 in Activated Pancreatic Stellate Cells and the Drug Resistance Problem in Pancreatic Cancer

  2017cites this paper
• A bifunctional aptamer for the targeted treatment of brain metastases

  2017influential citation
• Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines

  2017cites this paper
• Tetrahydroquinolinone derivatives as potent P-glycoprotein inhibitors: design, synthesis, biological evaluation and molecular docking analysis.

  2017cites this paper
• Redox regulation in tumor cell epithelial–mesenchymal transition: molecular basis and therapeutic strategy

  2017cites this paper
• Marine Sponge Natural Products with Anticancer Potential: An Updated Review

  2017cites this paper
• Tumor‐targeted nanomedicines for cancer theranostics

  2017cites this paper
• Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.

  2017cites this paper
• Reversion of P-gp-Mediated Drug Resistance in Ovarian Carcinoma Cells with PHPMA-Zosuquidar Conjugates.

  2017cites this paper
• Pitfalls and Opportunities for Epigenomic Analyses Focused on Disease Diagnosis, Prognosis, and Therapy.

  2017cites this paper
• Noncoding RNA in drug resistant sarcoma

  2017cites this paper
• Molecular Targets of Ascochlorin and Its Derivatives for Cancer Therapy.

  2017cites this paper
• The Role of Eukaryotic and Prokaryotic ABC Transporter Family in Failure of Chemotherapy

  2017cites this paper
• Sodium butyrate increases P-gp expression in lung cancer by upregulation of STAT3 and mRNA stabilization of ABCB1

  2017cites this paper
• CIP2A is associated with multidrug resistance in cervical adenocarcinoma by a P-glycoprotein pathway

  2016cites this paper
• P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SAR & Future Perspective for Drug Design.

  2016cites this paper
• Long non-coding RNAs in anti-cancer drug resistance

  2016cites this paper
• Epileptology - The Modern State of Science

  2016cites this paper
• MDR1 mediated chemoresistance: BMI1 and TIP60 in action.

  2016cites this paper
• Histone deacetylase inhibitors regulate P-gp expression in colorectal cancer via transcriptional activation and mRNA stabilization

  2016cites this paper
• A multimodal Pepstatin A peptide-based nanoagent for the molecular imaging of P-glycoprotein in the brains of epilepsy rats.

  2016cites this paper
• The role of the AHNAK protein in breast cancer : implications for tumour metastasis and chemoresistance

  2016cites this paper
• Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance.

  2016cites this paper
• Prolyl isomerase Pin1 regulates doxorubicin-inducible P-glycoprotein level by reducing Foxo3 stability.

  2016cites this paper
• Guest editorial: P-GLYCOPROTEIN TRANSPORTER IN DRUG DEVELOPMENT

  2016cites this paper
• Thiosemicarbazones Target Multiple Resistance Pathways in Cancer

  2016cites this paper
• Zeolite scaffolds for cultures of human breast cancer cells. Part II: Effect of pure and hybrid zeolite membranes on neoplastic and metastatic activity control.

  2016cites this paper
• P-glycoprotein transporter in drug development

  2016cites this paper
• Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines

  2016cites this paper
• Cetuximab directly inhibits P-glycoprotein function in vitro independently of EGFR binding.

  2015cites this paper
• P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases

  2015cites this paper
• MDRGene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines

  2015cites this paper
• Co-delivery of doxorubicin hydrochloride and verapamil hydrochloride by pH-sensitive polymersomes for the reversal of multidrug resistance

  2015cites this paper
• Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: ‘What does not kill me strengthens me'

  2015influential citation
• Drugs Affecting Epigenetic Modifications of ABC Transporters for Drug Resistance

  2015cites this paper
• Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy.

  2015cites this paper
• Análise da expressão de MDR1, MRP1, MRP2 e da superfamília EGFR nos carcinomas mamários esporádicos de cadelas

  2015cites this paper
• PLASMA GLYCOPROTEIN INHIBITORS AS A NEW TARGET FOR OPTIMAL DRUG DELIVERY

  2015cites this paper
• New insights into the mechanisms of multidrug resistance in cancers.

  2015cites this paper
• Expression of Multidrug Resistance ATP-Binding Cassette (ABC) Transporters in Canine Mammary Tumors

  2015cites this paper
• Gynura procumbens Prevents Chemoresistance through Inhibition MDR1 Expression on MCF-7 Breast Cancer Cell Line and Sensitizes the Cells to Doxorubicin

  2015cites this paper
• Selenorhodamine Photosensitizers for Photodynamic Therapy of P-Glycoprotein-Expressing Cancer Cells

  2014cites this paper
• Oleanolic and maslinic acid sensitize soft tissue sarcoma cells to doxorubicin by inhibiting the multidrug resistance protein MRP-1, but not P-glycoprotein.

  2014cites this paper
• Drug Resistance in Cancer: An Overview

  2014cites this paper
• 抗がん剤治療時における P-glycoproteinの発現・機能変動と薬物動態並びに薬理作用へ及ぼす影響

  2014cites this paper
• Mechanisms of P-glycoprotein alteration during anticancer treatment: role in the pharmacokinetic and pharmacological effects of various substrate drugs.

  2014cites this paper
• Cancer Biology and Signal Transduction Temozolomide Induces the Production of Epidermal Growth Factor to Regulate MDR 1 Expression in Glioblastoma Cells

  2014cites this paper
• ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.

  2014cites this paper
• Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line.

  2014cites this paper
• The role of ABC transporters in anticancer drug transport

  2014influential citation
• Temozolomide Induces the Production of Epidermal Growth Factor to Regulate MDR1 Expression in Glioblastoma Cells

  2014cites this paper
• The biology of MDR1-P-glycoprotein (MDR1-Pgp) in designing functional antibody drug conjugates (ADCs): the experience of gemtuzumab ozogamicin.

  2013cites this paper
• Anticancer Agent Shikonin Is an Incompetent Inducer of Cancer Drug Resistance

  2013cites this paper
• Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.

  2013cites this paper
• Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells

  2013cites this paper
• Nanopreparations to overcome multidrug resistance in cancer.

  2013cites this paper
• Egr-1 enhances drug resistance of breast cancer by modulating MDR1 expression in a GGPPS-independent manner.

  2013cites this paper
• Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines.

  2013cites this paper
• Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.

  2013cites this paper
• Accurate monitoring of promoter gene methylation with high-resolution melting polymerase chain reaction using the ABCB1 gene as a model.

  2013cites this paper